Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGEN CORP Director's Dealing 2017

Nov 21, 2017

32081_dirs_2017-11-20_b4f7583c-87cd-4386-a135-0427ffec387b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGEN CORP (NEOG)
CIK: 0000711377
Period of Report: 2017-11-17

Reporting Person: BRADLEY EDWARD (Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-17 Common Stock M 5700 $39.61 Acquired 27212 Direct
2017-11-17 Common Stock M 6124 $47.12 Acquired 33336 Direct
2017-11-17 Common Stock M 6000 $53.95 Acquired 39336 Direct
2017-11-17 Common Stock S 17824 $80.32 Disposed 21512 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-11-17 Common Stock (Right to Buy) $39.61 M 5700 Disposed 2019-10-31 Common Stock (5700) Direct
2017-11-17 Common Stock (Right to Buy) $47.12 M 6124 Disposed 2020-11-08 Common Stock (6124) Direct
2017-11-17 Common Stock (Right to Buy) $53.95 M 6000 Disposed 2021-10-29 Common Stock (6000) Direct

Footnotes

F1: Options were granted 10/1/2014, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant

F2: Options were granted 10/8/2015, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant

F3: Options were granted 9/29/2016, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant